RediChew Rx By vitaMedMD Overview & Drug Interactions

Check For Interactions With RediChew Rx

Supplement: RediChew Rx by vitaMedMD

RediChew Rx Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with RediChew Rx by vitaMedMD

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Pregnant and Lactating
Minimum serving Sizes:
1 Chewable Tablet(s)
Maximum serving Sizes:
1 Chewable Tablet(s)
Servings per container 30
UPC/BARCODE 310782-301-302

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Vitamin D3
400 IU
Vitamin D 100%
Vitamin B2
1.7 mg
Riboflavin 85%
Vitamin B6
2 mg
Vitamin B6 80%
Folate
1 mg
Folate 125%
Quatrefolic
600 mcg
5-methyltetrahydrofolate glucosamine
Folic Acid
400 mcg
Folate
Vitamin B12
8 mcg
Vitamin B12 100%

Other Ingredients:
Mannitol
Natural masking flavor
natural Vanilla flavor
Magnesium Stearate
Silica


Label Statments:


General Statements
- Product code 10782-301-30
- N
Formula
- With Quatrefolic
- Doctor-recommended for women planning a pregnancy and pregnant women with difficulty swallowing tablets or capsules
Formulation
- Chewable prenatal multivitamin
- Gluten, lactose and sugar-free
FDA Statement of Identity
- Dietary Supplement
Suggested/Recommended/Usage/Directions
- Suggested use: As a dietary supplement for women planning a pregnancy and for pregnant women with difficulty swallowing tablets or capsules, or where nausea or morning sickness makes taking tablets or capsules difficult, take one chewable tablet daily.
Precautions
- For adults only. Consult your doctor before taking any supplement.
- Keep this product out of the reach of children.
- Warning: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive. Contraindications: This product is contraindicated in patients with known hypersensitivity to any of the ingredients.
Brand IP Statement(s)
- Quatrefolic is a registered trademark of Gnosis Spa. U.S. Patent No. 7,947,662, and other patents pending.
Storage
- Keep in a cool, dry place, tightly closed.

Brand Information

See all products by this brand

Marketed and Distributed by
Name TherapeuticsMD
Street Address 951 Broken Sound Pkwy NW #320
City Boca Raton
State FL
ZipCode 33487
Phone Number 800.728.0009
Web Address wwww.TherapeuticsMD.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.